ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Storage: 2-8C
Application: Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected LDL Receptor in RAW264.7 and HEPG2 cell lysates.Immunohistochemistry (Paraffin) Analysis: A 1:100-1,000 dilution from a representative lot detected LDL Receptor in human liver and rat liver tissue sections.Immunocytochemistry Analysis: A 1:100 dilution of from a representative lot detected LDL Receptor in A431, HepG2, NIH 3T3 cells.Flow Cytometry Analysis: 0.1 mug from a representative lot detected LDL Receptor in HepG2.Note: Actual optimal working dilutions must be determined by the end user as specimens and experimental conditions may vary.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany